Real World Outcomes of Intravitreal Anti-vascular Endothelial Growth Factors for Neovascular Age Related Macular Degeneration in Taiwan
CompletedOBSERVATIONAL
Enrollment
63
Participants
Timeline
Start Date
April 3, 2017
Primary Completion Date
October 13, 2017
Study Completion Date
October 15, 2017
Conditions
AMD
Interventions
DRUG
Aflibercept [Eylea]
Anti-vascular endothelial growth factor (VEGF)
Trial Locations (1)
504
鄭**, Changhua
All Listed Sponsors
lead
Changhua Christian Hospital
OTHER
NCT03324542 - Real World Outcomes of Intravitreal Anti-vascular Endothelial Growth Factors for Neovascular Age Related Macular Degeneration in Taiwan | Biotech Hunter | Biotech Hunter